One hog production company found the estimated cost of swine influenza virus (SIV) to be $10.31 per market pig1; another large production system measured the cost of SIV through closeout to be $3.23 per pig2
SIV is one of the top three respiratory health challenges in terms of productivity losses and frequency of appearance3
Survey of 19 herds4 (50 percent of U.S. pork production in fall of 2005 and winter of 2006) indicate:
In breeding herds - SIV is a primary health challenge in 18 of 19 herds
In nursery - SIV is third to porcine reproductive and respiratory syndrome (PRRS) and Haemophilus parasuis
In finisher - SIV is second to Mycoplasma hyopneumoniae
Utilize appropriate vaccines to control SIV and reduce economic impact
Donovan TS. Influenza isolate selection methodology for timely autogenous vaccine use, in Proceedings. Amer Assoc Swine Vet Conf 2008; 557-561.
Dykhuis Haden C, Painter T, Fangman T and Holtkamp D. Assessing production parameters and economic impact of swine influenza, PRRS and Mycoplasma hyopneimoniae on finishing pigs in a large production system. Proceedings 2012 AASV Annual Meeting. p75-76.
Holtkamp D, Rotto H, Garcia R. The economic cost of major health challenges in large U.S. swine production systems, in Proceedings. Amer Assoc Swine Vet Conf 2007; 85-89.
USDA. 2008. Part IV: Changes in the U.S. Pork Industry, 1990-2006. USDA-APHIS-VS, CEAH. Fort Collins, CO.